Geode Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $125M | Sell |
|
|||||
|
2025
Q1 | $139M | Buy |
|
|||||
|
2024
Q4 | $127M | Buy |
|
|||||
|
2024
Q3 | $86.1M | Buy |
|
|||||
|
2024
Q2 | $112M | Buy |
|
|||||
|
2024
Q1 | $92.6M | Buy |
|
|||||
|
2023
Q4 | $77.8M | Buy |
|
|||||
|
2023
Q3 | $43.3M | Buy |
|
|||||
|
2023
Q2 | $62.7M | Buy |
|
|||||
|
2023
Q1 | $60.1M | Buy |
|
|||||
|
2022
Q4 | $68.7M | Buy |
|
|||||
|
2022
Q3 | $14.9M | Buy |
|
|||||
|
2022
Q2 | $16.1M | Buy |
|
|||||
|
2022
Q1 | $21.4M | Sell |
|
|||||
|
2021
Q4 | $18.6M | Buy |
|
|||||
|
2021
Q3 | $16.1M | Buy |
|
|||||
|
2021
Q2 | $19.3M | Buy |
|
|||||
|
2021
Q1 | $18.1M | Buy |
|
|||||
|
2020
Q4 | $15.8M | Buy |
|
|||||
|
2020
Q3 | $16.4M | Sell |
|
|||||
|
2020
Q2 | $15.7M | Sell |
|
|||||
|
2020
Q1 | $9.27M | Buy |
|
|||||
|
2019
Q4 | $11.3M | Buy |
|
|||||
|
2019
Q3 | $9.65M | Buy |
|
|||||
|
2019
Q2 | $11.5M | Buy |
|
|||||
|
2019
Q1 | $12.5M | Buy |
|
|||||
|
2018
Q4 | $10.2M | Buy |
|
|||||
|
2018
Q3 | $18.4M | Buy |
|
|||||
|
2018
Q2 | $22.4M | Buy |
|
|||||
|
2018
Q1 | $6.01M | Sell |
|
|||||
|
2017
Q4 | $4.98M | Buy |
|
|||||
|
2017
Q3 | $1.62M | Buy |
|
|||||
|
2017
Q2 | $524K | Buy |
|
|||||
|
2017
Q1 | $397K | Buy |
|
|||||
|
2016
Q4 | $381K | Buy |
|
|||||
|
2016
Q3 | $232K | Buy |
|
|||||
|
2016
Q2 | $166K | Sell |
|
|||||
|
2016
Q1 | $172 | Sell |
|
|||||
|
2015
Q4 | $252K | Buy |
|
|||||
|
2015
Q3 | $1.25M | Buy |
|
|||||
|
2015
Q2 | $1.49M | Buy |
|
|||||
|
2015
Q1 | $987K | Buy |
|
|||||
|
2014
Q4 | $1.16M | Buy |
|
|||||
|
2014
Q3 | $1.31M | Buy |
|
|||||
|
2014
Q2 | $1.59M | Buy |
|
|||||
|
2014
Q1 | $1.56M | Buy |
|
|||||
|
2013
Q4 | $1.4M | Buy |
|
|||||
|
2013
Q3 | $1.29M | Buy |
|
|||||
|
2013
Q2 | $915K | Buy |
|